RNF40

protein-coding

ring finger protein 40, the group of Ring finger proteins

Gene summary

The protein encoded by this gene contains a RING finger, a motif known to be involved in protein-protein and protein-DNA interactions. This protein was reported to interact with the tumor suppressor protein RB1. Studies of the rat counterpart suggested that this protein may function as an E3 ubiquitin-protein ligase, and facilitate the ubiquitination and degradation of syntaxin 1, which is an essential component of the neurotransmitter release machinery. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2011]

MANE transcript

NM_014771.4

Inheritance

AD

ClinVar variants

U:123B:5

Top phenotype

—

gnomAD constraint

pLI —, LoF o/e 0.13

Max pathogenic AF

—

Genomic locus

chr16:30,761,745-30,776,307

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~14.6 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

congenital heart diseaseLIMITED

Inheritance Pattern: AD

Disease ID:MONDO:0005453

Submitter: ClinGen

*RNF40* was first reported in relation to autosomal dominant congenital heart disease in 2017 (Jin et al. 2017, PMID:28991257). Only one splice site variant reported in an individual with congenital heart disease was included in this curation (PMID: 28991257, 31235600). This gene-disease relationship is also supported by a MO knockdown of *rnf20/rnf40* in Xenopus which showed abnormal heart looping, defective development of left–right (LR) asymmetry, and impaired cilia motility (PMID: 31235600). In summary, there is limited evidence supporting the relationship between *RNF40* and autosomal dominant congenital heart disease. Although more evidence is needed to support a causal role, no convincing evidence has emerged that contradicts the gene-disease relationship. This classification was approved by the ClinGen Congenital Heart Disease GCEP on the meeting date April 30th, 2024 (SOP Version 10).

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to RNF40 variants in ClinVar

2 Conditions Cataloged
not specifiedTotal: 114
not providedTotal: 4

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_014771.4. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
1
clinvar
2
clinvar
1
clinvar
4
missense
115
clinvar
2
clinvar
117
nonsense
1
clinvar
1
start loss
0
frameshift
0
splice donor/acceptor (+/-2bp)
6
clinvar
6
Total0012341128
Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 48 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_014771.4RefSeqNP_055586.119MANE Select
ENST00000324685.11EnsemblENSP00000325677.619MANE Select
NM_001207033.1RefSeqNP_001193962.119Standard
NM_001207034.1RefSeqNP_001193963.117Standard

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Pathways ConsensusPathDB

  • ATM Signaling Network in Development and Disease
  • Post-translational protein modification
  • Metabolism of proteins
  • Protein ubiquitination
  • E3 ubiquitin ligases ubiquitinate target proteins

Biological Process

  • ubiquitin-dependent protein catabolic process
  • regulation of mitotic cell cycle
  • histone monoubiquitination
  • protein ubiquitination
  • histone H2B ubiquitination

Molecular Function

  • mRNA 3'-UTR binding
  • ubiquitin-protein transferase activity
  • protein binding
  • syntaxin-1 binding
  • ubiquitin conjugating enzyme binding

Cellular Component

  • ubiquitin ligase complex
  • nucleus
  • nucleoplasm
  • cytosol
  • membrane

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000324685
Coding exons
19
Length
14563
Individuals with no LoFs
125651
Homozygous LoFs
0
Heterozygous LoFs
97
Defined
125748
p
0.000386
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense2.704396300.6970.00004226435
Missense (PolyPhen)62156.210.39691712
Synonymous1.182232470.9040.00001442032
Loss of Function6.27860.80.1320.00000395608

Population LoF Frequency

PopulationCAFp-valueStatus
African0.000250.00025rare
Latino/Admixed American0.0000580.000058rare
Ashkenazi Jewish0.0000990.000099rare
East Asian00.0absent
Finnish0.000140.00014rare
European (Non-Finnish)0.000780.00076rare
South Asian0.0000330.000033rare
Other00.0absent

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: Component of the RNF20/40 E3 ubiquitin-protein ligase complex that mediates monoubiquitination of 'Lys-120' of histone H2B (H2BK120ub1). H2BK120ub1 gives a specific tag for epigenetic transcriptional activation and is also prerequisite for histone H3 'Lys-4' and 'Lys-79' methylation (H3K4me and H3K79me, respectively). It thereby plays a central role in histone code and gene regulation. The RNF20/40 complex forms a H2B ubiquitin ligase complex in cooperation with the E2 enzyme UBE2A or UBE2B; reports about the cooperation with UBE2E1/UBCH are contradictory. Required for transcriptional activation of Hox genes. {ECO:0000269|PubMed:16307923, ECO:0000269|PubMed:19410543}.;

Recessive Scores

pRec
0.176

Intolerance Scores

LoFtool
0.457
RVIS EVS
-1.99
RVIS percentile EVS
1.76

Essentials

Essential (CRISPR)
E
Essential (CRISPR2)
E
Essential (gene trap)
E
Indispensability pred.
E
Indispensability score
0.674

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.